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ABSTRACT
The intrasynovial flexor tendons of the hand are critical for normal hand function.
Injury to these tendons can result in absent finger flexion, and a subsequent loss of
overall hand function. The surgical techniques used to repair these tendons have
improved in the past few decades, as have the postoperative rehabilitation protocols.
In spite of these advances, intrasynovial flexor tendon repairs continue to be plagued
by postoperative scar formation, which limits tendon gliding and prevents a full
functional recovery. This paper describes the current challenges of flexor tendon
repair, and evaluates the most recent advances and strategies for achieving an excel-
lent functional outcome.
The anatomy, physiology, and biomechanics of the
intrasynovial flexor tendons of the hand are unique in creating
distinctive challenges for successful tendon healing. The goal
of flexor tendon repair in the hand is not simply to achieve
healing but also to restore tendon gliding to achieve functional
finger motion. Healing after flexor tendon repair can be readily
accomplished with finger immobilization. However, if the digit
is immobilized until tendon healing occurs, the tendon will
become adherent to the surrounding tissue that finger motion is
lost. On the other hand, early active movement after tendon
repair allows the tendon to heal with fewer adhesions but risks
tendon rupture.
Tendons heal through a combination of two distinct mecha-
nisms: extrinsic and intrinsic tendon healing. Both mecha-
nisms follow the schema of healing that is common to many
tissue types, which includes an inflammatory period of 48–72
hours, fibroblast proliferation, and collagen production
lasting 3–4 weeks, followed finally by a period of remodeling,
involving collagen cross-linking, reduction of type III
collagen, and reorientation of collagen fibers. Extrinsic
healing is characterized by the rapid influx of fibroblasts from
peritendinous tissue that promote adhesions between the
tendon and surrounding tissue. In contrast, intrinsic healing
occurs via fibroblasts originating from the endotenon and the
tendon itself without adhesion formation, ultimately resulting
in greater strength at the repair site, and is facilitated by early
mobilization.
In spite of advances in surgical technique and postoperative
rehabilitation protocols, the goal of successful tendon healing
without adhesions is difficult to achieve. Patients and sur-
geons continue to struggle with postoperative issues such as
loss of motion and tendon rupture. Because of this, numerous
strategies for optimizing flexor tendon healing have been
studied in the clinical and laboratory settings. In general,
these strategies are aimed at four areas. These include (1)
rehabilitation protocols, (2) surgical technique and suture
material, (3) surface modification and adhesion barriers, and
(4) delivery of growth factors.
REHABILITATION
Multiple studies have showed that early controlled motion
after flexor tendon repair in the hand results in improved
motion.1–8 A multitude of early motion rehabilitation protocols
has been described9–19 and can be divided into early active and
early passive motion protocols. The goal of both types of
rehabilitation is to initiate a protected movement of the
repaired tendon within the tendon sheath, thereby promoting
primary tendon healing and limiting adhesion formation.
Unfortunately, although there are hundreds of clinical studies
that evaluate the outcomes of different rehabilitation proto-
cols, until recently, there has not been one randomized com-
parative trial.20 In 2010, Trumble and colleagues published a
prospective randomized clinical trial comparing early active
(place and hold) with early passive motion.21 The study
showed better finger range of motion in patients who received
the early active rehabilitation protocol, with no increase in
tendon rupture rate.
However, much remains unknown about the relative merits
of different flexor tendon rehabilitation protocols. For
example, is composite active motion in which the fingers are
moved from an extended position to a flexed position under
the power of the forearm muscles (such as is used in the
Belfast protocol)17 preferable to active place and hold? Fur-
thermore, many therapists practice a variation of a standard
published protocol, such as the timing of advancement within
the protocol, when tendon gliding is initiated, when blocking
is initiated, when passive extension is initiated, and how
edema control is performed. It is unknown what impact these
common practice variations have on outcomes. There is a
need for large randomized clinical trials designed to answer
these questions. It is also important for future trials to be
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consistent in their outcome measurements so that subsequent
data aggregation and meta-analysis can be performed. Active
finger motion and tendon rupture rate are critical outcome
measurements. However, many other outcome measurements
are also important. In addition to composite active finger
motion, individual joint motion and passive motion should be
reported. Grip and pinch strength, as well as an objective
measure of hand dexterity and overall function such as the
Jebsen-Taylor test,22 should be presented. In addition to objec-
tive measures of function, patient-rated outcomes should be a
component in any future studies of flexor tendon rehabilita-
tion. These outcomes tools include the Michigan Hand Ques-
tionnaire (MHQ), and the disabilities of the arm, shoulder,
and hand, which are two well-established instruments that
measure patient-rated hand function. The MHQ is particularly
useful because it evaluates hand function in multiple domains
of hand use and includes a measurement of pain.23–29 Finally,
with the current emphasis on the rising cost of medical care,
future studies must also measure the cost-effectiveness of
various rehabilitation protocols.
SURGICAL TECHNIQUE/SUTURE MATERIAL
An ideal flexor tendon repair must be strong enough to with-
stand an early passive or active motion rehabilitation protocol.
Furthermore, the repair should be technically straight
forward, result in minimal suture burden, and should not
adversely affect tendon gliding or healing. Many techniques
for flexor tendon repair have been described and studied,
including the Kessler, modified Kessler, Tajima-Kessler,
Bunnell, Tsuge, Indiana/Strickland, Gelberman, locked cruci-
ate, and many others.30–40 A number of factors have emerged
as being important. The strength of the core repair is propor-
tional to the number of suture strands that cross the repair
site.40 The strength of the repair is also proportional to the
suture diameter and to the strength of the suture material
itself.40,41 Locking bites in the core repair reduce failure by
suture pullout. Finally, the use of an epitendinous suture
decreases gapping at the repair site during loading and
increases repair strength by as much as 20%.41 Based on these
findings, most surgeons employ a four-strand core repair
using 4-0 or 3-0 suture and use an epitendinous suture.40
Recent investigations have explored the potential role of
barbed suture in flexor tendon repairs. The barbs on the
surface of the suture pierce the tissue at multiple points along
the course of the suture, resulting in increased resistance to
pullout. Because barbed suture “grasps” the tissue it passes
through, tension is distributed along the course of the suture
material, and knots are not required. The potential advantage
of barbed suture in flexor tendon repair arises from the fact
that the repair would be knotless. Standard suture repairs
require one or more knots that are placed on the tendon
surface or within the repair site, depending upon the repair
technique. External knots located on the tendon surface inter-
fere with tendon gliding and can catch on the flexor tendon
sheath. Knots within the repair site reduce the contact surface
of the tendon ends and might adversely affect tendon healing.
A knotless repair would obviate these problems.
Recent cadaveric studies have shown that four-strand
barbed suture knotless repairs can have similar biomechanical
characteristics to standard knotted four-strand repairs in terms
of load to failure and gapping characteristics.42–44 However,
much remains unknown about how barbed suture repairs
might perform in vivo. For one, none of these repairs have
been studied with cyclical loading, which is a more meaning-
ful and physiologic way to load tendon repairs. Furthermore,
no studies have been performed to examine the effect of
barbed sutures on tendon gliding or adhesion formation.
Finally, because barbed suture is not specifically designed for
use in tendons, it is possible that an alternative barb configu-
ration may prove to be superior to the currently available
sutures. For example, barb size, angle, density, orientation,
and configuration could all be optimized for use in tendon
tissue. Future research should be directed toward studying the
response of barbed suture knotless repairs to cyclical loading,
the effect of barbed suture repairs on tendon gliding resistance
and adhesion formation, and on optimizing barb characteris-
tics for use in tendon tissue.
SURFACE MODIFICATION/ADHESION
BARRIERS
The goal of both tendon surface modification and adhesion
barriers is to improve gliding. Surface modification involves
applying a substance to the surface of the repaired tendon
in order to alter the physical properties of the tendon to
make it glide more smoothly. Adhesion barriers refer
to physical or chemical barriers that are applied to the
tendon in an attempt to minimize adhesion formation. Numer-
ous physical barriers to adhesion formation have been
studied, including the application of silicone, polyethylene
membranes, alumina shields, polytetrafluoroethylene, and
polyhydroxyethylmethylmethacrylate membranes.45–51 None
of these have been successful enough to be used clinically.
Other investigators have focused on chemical barriers to
adhesion formation, including corticosteroids, 5-flurouracil,
alginate, or other substances.52–61 None of these chemical bar-
riers to adhesion formation have been found to be applicable
clinically, usually due to the short duration of effect or
because of an adverse effect on tendon healing. Other inves-
tigators are currently focusing on modifying the tendon
surface in such a way as to improve gliding during the reha-
bilitation period, as opposed to attempting to directly reduce
adhesion formation. Hyaluronic acid, a glucosaminoglycan,
combined with gelatin and lubricin, a glycoprotein, has been
used to modify the surface of tendons in a canine model of
flexor tendon repair.62 The work of flexion was decreased in
treated tendons. However, repair site strength was also
decreased. It is not known what substance, if any, can be
applied topically to the repaired tendon to reduce adhesion
formation or to promote gliding. The key problems appear to
be that many substances that promote gliding or decrease
adhesion formation fail to persist long enough to be clinically
effective and that many of the substances also adversely affect
tendon healing. Future research is likely to focus on improv-
ing the half life or durability of these substances and on
protecting the repair site from the effects of the substance.
DELIVERY OF GROWTH FACTORS
A major focus of recent tendon healing research is on inter-
ventions that alter the molecular milieu of the healing tendon,
by adding or modulating growth factors in an attempt to
augment healing. The temporal, spatial, and quantitative
expression of cytokines as well as their roles and interactions
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during the healing of flexor tendons is extremely complex and
is not well understood. Some of the cytokines that have been
found to play central roles in flexor tendon healing include
platelet-derived growth factor BB (PDGF-BB), beta-
fibroblast growth factor (β-FGF), transforming growth factor
beta, and bone morphogenic proteins 12, 13, and 14 (BMP 12,
13, 14). Several methods for delivering cytokines to the repair
site have been devised, including fabricated biologic delivery
systems, the introduction of stem cells (with or without gene
transfer), adenoviral vectors, the use of platelet rich plasma,
and others. Bone marrow-derived stromal cells (BMSCs)
have been implanted between the lacerated ends of repaired
tendons in an in vitro model and have shown increased
maximal strength and stiffness compared with controls.63 The
introduction of BMP 12, 13, 14, or β-FGF to a tendon repair
site by adenovirus-mediated gene transfer or other means has
been shown to augment tendon healing in in vivo animal
models as well.64–67 PDGF-BB has been shown to increase
collagen production in an in vivo canine model, when intro-
duced using a collagen patch interposed at the repair site, and
has been shown to increase remodeling as well as improve
the structural and biomechanical properties of healing
tendons.68–70 A more sophisticated delivery system for
PDGF-BB has been fabricated, which employs heparin
binding to control the release of PDGF-BB over time.71 The
use of platelet-rich plasma (PRP) has been investigated as
well. Although it does not seem to augment tendon healing
alone, PRP was found to enhance the effects of a BMSC-
seeded collagen patch in an in vitro.72 Finally, synovial tissue
(synovium), which is present and readily accessible during
flexor tendon repair, is a source of cells and cytokines. In a
canine tendon explant culture model, a synovial patch inter-
posed at the repair site was shown to result in increased repair
strength compared with controls.73
All of these interventions are in the early stages of inves-
tigation and are not ready for clinical application at this time.
Many questions remain unanswered. Which cytokines, in
what combination, at what time, and at what concentration
should be delivered to the repair site? What is the ideal deliv-
ery device or method: adenoviral vector, fabricated patch,
stem cells (adipose or bone marrow derived, autologous or
allogeneic), or other? In addition, the in vivo effects in
humans on tendon healing, tendon gliding, inflammation, and
adhesion formation are completely unknown.
In conclusion, the goal of flexor tendon repair in the hand
is to achieve tendon healing without adhesion formation,
resulting in a healed tendon that glides freely within the flexor
tendon sheath. In an effort to augment tendon healing and/or
minimize adhesion formation, investigations are underway in
multiple arenas, including rehabilitation protocols, surgical
technique and suture material, surface modification and adhe-
sion barriers, and the delivery of growth factors. Further study
is required. Many of the important questions and measure-
ments for quantifying answers to those questions have been
discussed.
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